Table 7.
Effects of intervention with placebo and PVE on body weight, body fat mass, body fat, overweight, and body mass index (BMI) in obese subjects
| Placebo (n = 58) | D‐value | p value | PVE (n = 56) | D‐value | P value | |||
|---|---|---|---|---|---|---|---|---|
| Baseline | 35 Days | Baseline | 35 Days | |||||
| Body weight (kg) | 83.81 ± 4.72 | 83.52 ± 4.70 | 0.29 ± 0.30 | >.05 | 82.87 ± 4.75 | 80.63 ± 5.02* | 2.24 ± 1.27** | <.01 |
| Body fat mass (kg) | 26.18 ± 2.43 | 25.68 ± 2.40 | 0.50 ± 0.61 | >.05 | 26.61 ± 2.13 | 24.65 ± 2.61* | 1.95 ± 0.44** | <.01 |
| Body fat (%) | 31.32 ± 3.25 | 30.28 ± 3.24 | 0.49 ± 0.66 | >.05 | 32.23 ± 3.28 | 30.69 ± 3.71 | 1.53 ± 1.68** | <.01 |
| Overweight (%) | 32.60 ± 5.00 | 32.14 ± 5.04 | 0.45 ± 0.48 | >.05 | 33.49 ± 5.26 | 29.82 ± 4.62* | 3.66 ± 2.04** | <.01 |
| BMI (kg/m2) | 28.87 ± 0.83 | 28.77 ± 0.84 | 0.10 ± 0.10 | >.05 | 28.97 ± 0.90 | 28.17 ± 0.82* | 0.79 ± 0.44** | <.01 |
Data are shown as means ± standard deviation. Among various parameters, a comparison of the individual changes (35 day values—baseline) was made both within groups and between the placebo and PVE groups. p values correspond to the comparison of baseline and 35 days within each treatment.
*
Significant difference between the placebo and PVE groups (p < .05).
**
Indicates significant difference between the placebo and PVE groups (p < .01).